[#item_full_content] [[{“value”:”Federal rescheduling of medical marijuana to Schedule III has turned a complex policy story into a real money question for U.S. cannabis operators like Trulieve, Curaleaf and Green Thumb Industries. Tax relief, shifting politics and fresh regulatory risks are all converging at once. This article walks through three stocks from our U.S. Cannabis Operators screener that are directly exposed to this news, and what that could mean for your portfolio decisions.
The three stocks highlighted below…”}]] Read More
Trulieve Stock And 2 U.S. Cannabis Operators Poised For Schedule III Tax Relief
ByPot Shop News
August 16, 2026